World's Best Scientists 2026 revealed!
Award Badge
Molecular Biology
USA
2025

D-Index & Metrics

Discipline name D-Index World Ranking Current World Ranking National Ranking Current National Ranking Publications Citations
Genetics 129 262 253 136 131 462 65585
Molecular Biology 129 192 173 119 107 462 65585

Mark A. Kay publications per year

The chart shows the history of publications by Mark A. Kay between 1985 and 2025, highlighting the no. of papers published in each year and offering an overview of the publication velocity of this scholar. Mark A. Kay published across 41 years, from 1985 to 2025, averaging 12.6 papers a year. Output peaked at 44 publications in 2005. 15 of the 515 publications appeared in the last two years.

No. of publications
10 20 30 40
Bar chart. Horizontal axis: year, 1985 to 2025. Vertical axis: number of publications, 0 to 44. Peak 44 publications in 2005. 1985: 2 publications 1986: 0 publications 1987: 2 publications 1988: 1 publication 1989: 0 publications 1990: 2 publications 1991: 0 publications 1992: 4 publications 1993: 6 publications 1994: 4 publications 1995: 18 publications 1996: 10 publications 1997: 21 publications 1998: 9 publications 1999: 12 publications 2000: 16 publications 2001: 14 publications 2002: 19 publications 2003: 28 publications 2004: 34 publications 2005: 44 publications 2006: 39 publications 2007: 25 publications 2008: 16 publications 2009: 7 publications 2010: 19 publications 2011: 18 publications 2012: 14 publications 2013: 10 publications 2014: 16 publications 2015: 15 publications 2016: 18 publications 2017: 12 publications 2018: 7 publications 2019: 7 publications 2020: 10 publications 2021: 8 publications 2022: 9 publications 2023: 4 publications 2024: 6 publications 2025: 9 publications
1985 2025

515 publications in total across all disciplines

View publications per year as a table
Mark A. Kay: publications per year, 1985 to 2025
Year Publications
1985 2
1986 0
1987 2
1988 1
1989 0
1990 2
1991 0
1992 4
1993 6
1994 4
1995 18
1996 10
1997 21
1998 9
1999 12
2000 16
2001 14
2002 19
2003 28
2004 34
2005 44
2006 39
2007 25
2008 16
2009 7
2010 19
2011 18
2012 14
2013 10
2014 16
2015 15
2016 18
2017 12
2018 7
2019 7
2020 10
2021 8
2022 9
2023 4
2024 6
2025 9
Total 515
Download as CSV

Mark A. Kay publications per year - data summary

  • Mark A. Kay, a Molecular Biology scholar from Stanford University, has 515 publications recorded across 41 years, from 1985 to 2025.
  • The oldest publication on record dates to 1985 and the most recent to 2025.
  • The most productive year is 2005, with 44 publications.
  • The least productive year with any output is 1988, with 1 publication.
  • 3 of the 41 years in the span carry no publications at all (1986, 1989 and 1991).
  • The rate of publication averages 12.6 papers per year over the whole span, or 13.6 per year counting only the 38 years with at least one publication.
  • The last 5 years on the chart (2021-2025) hold 36 publications, 7% of the career total.
  • Split into equal eras - 1985-1998: 79 publications (5.6 per year); 1999-2012: 305 publications (21.8 per year); 2013-2025: 131 publications (10.1 per year).
  • Comparing the opening and closing eras, the overall trend of publication is rising.

Mark A. Kay publication distribution in Molecular Biology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Molecular Biology in 2026. The highlighted bar marks where Mark A. Kay sits on this spectrum.

No. of scientists
50 100 150
Bar chart with 53 bars. Horizontal axis: publications, 47–56 to 564+. Vertical axis: number of scientists, 0 to 177. Most scientists, 177, have 117–126 publications. The last bar groups every scientist with 564 publications or more. The highlighted bar, 457–466 publications, is where this scientist sits. 47–56 publications: 7 scientists 57–66 publications: 17 scientists 67–76 publications: 65 scientists 77–86 publications: 90 scientists 87–96 publications: 125 scientists 97–106 publications: 131 scientists 107–116 publications: 162 scientists 117–126 publications: 177 scientists 127–136 publications: 158 scientists 137–146 publications: 158 scientists 147–156 publications: 146 scientists 157–166 publications: 159 scientists 167–176 publications: 131 scientists 177–186 publications: 110 scientists 187–196 publications: 112 scientists 197–206 publications: 100 scientists 207–216 publications: 89 scientists 217–226 publications: 98 scientists 227–236 publications: 74 scientists 237–246 publications: 72 scientists 247–256 publications: 63 scientists 257–266 publications: 53 scientists 267–276 publications: 54 scientists 277–286 publications: 49 scientists 287–296 publications: 52 scientists 297–306 publications: 43 scientists 307–316 publications: 46 scientists 317–326 publications: 41 scientists 327–336 publications: 42 scientists 337–346 publications: 31 scientists 347–356 publications: 28 scientists 357–366 publications: 29 scientists 367–376 publications: 26 scientists 377–386 publications: 24 scientists 387–396 publications: 24 scientists 397–406 publications: 14 scientists 407–416 publications: 13 scientists 417–426 publications: 20 scientists 427–436 publications: 12 scientists 437–446 publications: 20 scientists 447–456 publications: 11 scientists 457–466 publications: 10 scientists 467–476 publications: 14 scientists 477–486 publications: 14 scientists 487–496 publications: 10 scientists 497–506 publications: 13 scientists 507–516 publications: 13 scientists 517–526 publications: 2 scientists 527–536 publications: 4 scientists 537–546 publications: 6 scientists 547–556 publications: 8 scientists 557–563 publications: 6 scientists 564+ publications: 100 scientists
47–56 publications 564+

This scientist: 462 publications — 94th percentile

94% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 564 publications or more.

View publications distribution as a table
Number of Molecular Biology scientists by publication count, Research.com 2026 ranking edition. Based on 3,076 ranked scientists.
Publications Scientists This scientist
47–56 7
57–66 17
67–76 65
77–86 90
87–96 125
97–106 131
107–116 162
117–126 177
127–136 158
137–146 158
147–156 146
157–166 159
167–176 131
177–186 110
187–196 112
197–206 100
207–216 89
217–226 98
227–236 74
237–246 72
247–256 63
257–266 53
267–276 54
277–286 49
287–296 52
297–306 43
307–316 46
317–326 41
327–336 42
337–346 31
347–356 28
357–366 29
367–376 26
377–386 24
387–396 24
397–406 14
407–416 13
417–426 20
427–436 12
437–446 20
447–456 11
457–466 10 462
467–476 14
477–486 14
487–496 10
497–506 13
507–516 13
517–526 2
527–536 4
537–546 6
547–556 8
557–563 6
564+ 100
Download as CSV

Mark A. Kay publication distribution in Molecular Biology in 2026 - data summary

  • The chart plots the publication count of all 3,076 Molecular Biology scientists ranked by Research.com in 2026, grouped into 53 ranges running from 47–56 to 564+ publications.
  • Mark A. Kay, a Molecular Biology scholar from Stanford University, records 462 publications - the 94th percentile of the discipline.
  • 94% of ranked Molecular Biology scientists score the same or lower than Mark A. Kay, and about 6% score higher.
  • The median of the discipline falls in the 177–186 publications range, and Mark A. Kay ranks above the median.
  • The most crowded range is 117–126 publications, holding 177 scientists (6% of the field).
  • 53% of the field sits in the lowest quarter of the value range (up to 177–186 publications), so the distribution is heavily right-skewed and high scores are rare.
  • The final bar has no upper bound: it groups every scientist with 564 publications or more, 100 scientists in all (3% of the field).

Mark A. Kay D-index placement in Molecular Biology in 2026

The chart shows the D-index (discipline H-index) distribution of Molecular Biology scientists ranked by Research.com in 2026. The highlighted bar marks where Mark A. Kay sits on this spectrum.

No. of scientists
25 50 75 100 125
Bar chart with 54 bars. Horizontal axis: D-Index, 40–41 to 145+. Vertical axis: number of scientists, 0 to 131. Most scientists, 131, have 64–65 D-Index. The last bar groups every scientist with 145 D-Index or more. The highlighted bar, 128–129 D-Index, is where this scientist sits. 40–41 D-Index: 36 scientists 42–43 D-Index: 101 scientists 44–45 D-Index: 115 scientists 46–47 D-Index: 121 scientists 48–49 D-Index: 118 scientists 50–51 D-Index: 130 scientists 52–53 D-Index: 106 scientists 54–55 D-Index: 116 scientists 56–57 D-Index: 113 scientists 58–59 D-Index: 129 scientists 60–61 D-Index: 120 scientists 62–63 D-Index: 105 scientists 64–65 D-Index: 131 scientists 66–67 D-Index: 95 scientists 68–69 D-Index: 97 scientists 70–71 D-Index: 106 scientists 72–73 D-Index: 83 scientists 74–75 D-Index: 89 scientists 76–77 D-Index: 77 scientists 78–79 D-Index: 70 scientists 80–81 D-Index: 73 scientists 82–83 D-Index: 60 scientists 84–85 D-Index: 48 scientists 86–87 D-Index: 45 scientists 88–89 D-Index: 50 scientists 90–91 D-Index: 31 scientists 92–93 D-Index: 51 scientists 94–95 D-Index: 43 scientists 96–97 D-Index: 38 scientists 98–99 D-Index: 39 scientists 100–101 D-Index: 41 scientists 102–103 D-Index: 29 scientists 104–105 D-Index: 33 scientists 106–107 D-Index: 35 scientists 108–109 D-Index: 20 scientists 110–111 D-Index: 38 scientists 112–113 D-Index: 19 scientists 114–115 D-Index: 28 scientists 116–117 D-Index: 13 scientists 118–119 D-Index: 23 scientists 120–121 D-Index: 16 scientists 122–123 D-Index: 15 scientists 124–125 D-Index: 11 scientists 126–127 D-Index: 21 scientists 128–129 D-Index: 7 scientists 130–131 D-Index: 13 scientists 132–133 D-Index: 14 scientists 134–135 D-Index: 17 scientists 136–137 D-Index: 9 scientists 138–139 D-Index: 8 scientists 140–141 D-Index: 16 scientists 142–143 D-Index: 7 scientists 144 D-Index: 7 scientists 145+ D-Index: 100 scientists
40–41 D-Index 145+

This scientist: 129 D-Index — 94th percentile

94% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 145 D-Index or more.

View D-Index distribution as a table
Number of Molecular Biology scientists by D-index, Research.com 2026 ranking edition. Based on 3,076 ranked scientists.
D-Index Scientists This scientist
40–41 36
42–43 101
44–45 115
46–47 121
48–49 118
50–51 130
52–53 106
54–55 116
56–57 113
58–59 129
60–61 120
62–63 105
64–65 131
66–67 95
68–69 97
70–71 106
72–73 83
74–75 89
76–77 77
78–79 70
80–81 73
82–83 60
84–85 48
86–87 45
88–89 50
90–91 31
92–93 51
94–95 43
96–97 38
98–99 39
100–101 41
102–103 29
104–105 33
106–107 35
108–109 20
110–111 38
112–113 19
114–115 28
116–117 13
118–119 23
120–121 16
122–123 15
124–125 11
126–127 21
128–129 7 129
130–131 13
132–133 14
134–135 17
136–137 9
138–139 8
140–141 16
142–143 7
144 7
145+ 100
Download as CSV

Mark A. Kay D-index placement in Molecular Biology in 2026 - data summary

  • The chart plots the discipline H-index (D-index) of all 3,076 Molecular Biology scientists ranked by Research.com in 2026, grouped into 54 ranges running from 40–41 to 145+ D-Index.
  • Mark A. Kay, a Molecular Biology scholar from Stanford University, records 129 D-Index - the 94th percentile of the discipline.
  • 94% of ranked Molecular Biology scientists score the same or lower than Mark A. Kay, and about 6% score higher.
  • The median of the discipline falls in the 68–69 D-Index range, and Mark A. Kay ranks above the median.
  • The most crowded range is 64–65 D-Index, holding 131 scientists (4% of the field).
  • 50% of the field sits in the lowest quarter of the value range (up to 66–67 D-Index), so the distribution leans towards the lower end of the scale.
  • The final bar has no upper bound: it groups every scientist with 145 D-Index or more, 100 scientists in all (3% of the field).

Research.com Recognitions

  • 2025 - Research.com Molecular Biology in United States Leader Award
  • 2023 - Research.com Molecular Biology in United States Leader Award
  • 2020 - Fellow, National Academy of Inventors

Overview

Mark A. Kay is affiliated with Stanford University in the United States. Their research primarily spans the fields of Biochemistry, Genetics, and Molecular Biology, with notable contributions in Medicine as well. Within these domains, their work focuses on subfields such as Molecular Biology, Genetics, Cancer Research, Oncology, and Epidemiology.

The scientist's research topics include:

  • CRISPR and Genetic Engineering
  • Virus-based gene therapy research
  • RNA modifications and cancer
  • RNA and protein synthesis mechanisms
  • RNA Interference and Gene Delivery
  • CAR-T cell therapy research
  • Cancer-related molecular mechanisms research

Mark A. Kay's most frequent publication venues are:

  • Molecular Therapy
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Nature Communications
  • Molecular Therapy - Methods & Clinical Development
  • UNC Libraries

Frequent co-authors include:

  • Katja Pekrun
  • Feijie Zhang
  • Hak Kyun Kim
  • Jianpeng Xu
  • Francesco Puzzo

Notable recent papers authored or co-authored by Mark A. Kay are:

  • Novel NanoLuc substrates enable bright two-population bioluminescence imaging in animals, 2020, Nature Methods
  • Evaluating the state of the science for adeno-associated virus integration: An integrated perspective, 2022, Molecular Therapy
  • Transfer RNA-Derived Small RNAs: Another Layer of Gene Regulation and Novel Targets for Disease Therapeutics, 2020, Molecular Therapy
  • A standardized ontology for naming tRNA-derived RNAs based on molecular origin, 2023, Nature Methods
  • RNA structure probing reveals the structural basis of Dicer binding and cleavage, 2021, Nature Communications

Mark A. Kay has been recognized with the award of Fellow, National Academy of Inventors in 2020.

Best Publications

  • Progress and problems with the use of viral vectors for gene therapy

    Clare E. Thomas;Anja Ehrhardt;Mark A. Kay

  • Successful transduction of liver in hemophilia by AAV-Factor IX and limitations imposed by the host immune response

    Manno Cs;Pierce Gf;Arruda Vr;Glader B

  • Adenovirus-Associated Virus Vector–Mediated Gene Transfer in Hemophilia B

    Amit C. Nathwani;Edward G.D. Tuddenham;Savita Rangarajan;Cecilia Rosales

  • Fatality in mice due to oversaturation of cellular microRNA/short hairpin RNA pathways.

    Dirk Grimm;Konrad L. Streetz;Konrad L. Streetz;Catherine L. Jopling;Theresa A. Storm

  • Viral vectors for gene therapy: the art of turning infectious agents into vehicles of therapeutics

    Mark A. Kay;Joseph C Glorioso;Luigi Naldini

  • RNA interference in adult mice.

    Anton P. McCaffrey;Leonard Meuse;Thu-Thao T. Pham;Douglas S. Conklin

  • Long-term safety and efficacy of factor IX gene therapy in hemophilia B

    Amit C Nathwani;Ulreke M Reiss;Edward G D Tuddenham;Cecilia Rosales;Cecilia Rosales

  • Evidence for gene transfer and expression of factor IX in haemophilia B patients treated with an AAV vector

    Mark A. Kay;Catherine S. Manno;Catherine S. Manno;Margaret V. Ragni;Peter J. Larson;Peter J. Larson

  • Inhibition of hepatitis B virus in mice by RNA interference.

    Anton P McCaffrey;Hiroyuki Nakai;Kusum Pandey;Zan Huang

  • A nonviral minicircle vector for deriving human iPS cells

    Fangjun Jia;Kitchener D Wilson;Ning Sun;Deepak M Gupta

  • AAV-mediated factor IX gene transfer to skeletal muscle in patients with severe hemophilia B.

    Catherine S. Manno;Amy J. Chew;Sylvia Hutchison;Peter J. Larson

  • Robust expansion of human hepatocytes in Fah −/− / Rag2 −/− / Il2rg −/− mice

    Hisaya Azuma;Nicole Paulk;Aarati Ranade;Craig Dorrell

  • Sarcoma derived from cultured mesenchymal stem cells

    Jakub Tolar;Alma J. Nauta;Mark J. Osborn;Angela Panoskaltsis Mortari

  • State-of-the-art gene-based therapies: the road ahead.

    Mark A. Kay

  • In Vitro and In Vivo Gene Therapy Vector Evolution via Multispecies Interbreeding and Retargeting of Adeno-Associated Viruses

    Dirk Grimm;Joyce S. Lee;Lora Wang;Tushar Desai

  • In vivo activity of nuclease-resistant siRNAs.

    Juliana M. Layzer;Anton P. Mccaffrey;Alice K. Tanner;Zan Huang

  • Persistent and therapeutic concentrations of human factor IX in mice after hepatic gene transfer of recombinant AAV vectors

    R O Snyder;C H Miao;G A Patijn;S K Spratt

  • Human tRNA-derived small RNAs in the global regulation of RNA silencing

    Dirk Haussecker;Yong Huang;Ashley Lau;Poornima Parameswaran

  • Robust systemic transduction with AAV9 vectors in mice: efficient global cardiac gene transfer superior to that of AAV8

    Katsuya Inagaki;Sally Fuess;Theresa A. Storm;Gregory A. Gibson

  • Correction of hemophilia B in canine and murine models using recombinant adeno-associated viral vectors

    Richard O. Snyder;Carol Miao;Leonard Meuse;Julie Tubb

Frequent Co-Authors

Dirk Grimm
Dirk Grimm Heidelberg University
André Lieber
André Lieber University of Washington
Katherine A. High
Katherine A. High Children's Hospital of Philadelphia
Markus Grompe
Markus Grompe Oregon Health & Science University
Andrew Fire
Andrew Fire Stanford University
Milton J. Finegold
Milton J. Finegold Baylor College of Medicine
Joseph C. Wu
Joseph C. Wu Stanford University
Savio L. C. Woo
Savio L. C. Woo Icahn School of Medicine at Mount Sinai
Robert C. Robbins
Robert C. Robbins Stanford University
Jakub Tolar
Jakub Tolar University of Minnesota

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Molecular Biology in the USA opens doors to diverse and dynamic career opportunities in both research and healthcare sectors. For professionals seeking to expand their expertise or transition into clinical roles, online degree options can provide flexible and accelerated pathways.

Many students interested in applying biological science knowledge to patient care may consider nursing. Programs such as the best online bsn programs for non nurses allow science graduates to pivot into nursing efficiently, making use of their prior academic credits.

Those who hold an RN license and want to advance further can explore a 6-month rn to bsn program, designed for rapid upskilling. These online options not only save time but can also reduce overall education costs.

For scientists interested in advanced clinical practice, learning how to become a np (Nurse Practitioner) is valuable. This route empowers graduates to assess, diagnose, and manage patient health.

Molecular biology knowledge is especially useful in specialized fields, such as psychiatric care. Salaries in these professions are promising; you can see compensation trends by visiting the psych np salary page.

Best Scientists Citing Mark A. Kay

Trending Scientists

Recently Published Articles